Author:
Pratley R. E.,Schweizer A.,Rosenstock J.,Foley J. E.,Banerji M. A.,Pi-Sunyer F. X.,Mills D.,Dejager S.
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference12 articles.
1. Vildagliptin in drug-naive patients with type 2 diabetes: a 24-week, double-blind, randomized, placebo-controlled, multiple-dose study;Dejager;Horm Metab Res,2007
2. Efficacy and tolerability of vildagliptin monotherapy in drug-naive patients with type 2 diabetes;Pi-Sunyer;Diabetes Res Clin Pract,2007
3. Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial;Rosenstock;Diabetes Care,2007
4. Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared to component monotherapy in patients with type 2 diabetes;Rosenstock;Diabetes Obes Metab,2007
5. Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels and reduces glucagon levels in type 2 diabetes;Ahrén;J Clin Endocrinol Metab,2004
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献